Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
ELZONRIS Inf Konz 1 mg/ml Durchstf 1 ml
Drug
Elzonris 1mg / ml, Konzentrat zur Herstellung einer Infusionslösung
Blastische plasmazytoide dendritische Zellneoplasie (BPDCN)
07.16.4. – others
HAM – Human medicine
KOINF – Concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
2/3/2023
2/2/2028
Dosage strength
Elzonris 1mg / ml, Konzentrat zur Herstellung einer Infusionslösung
Blastische plasmazytoide dendritische Zellneoplasie (BPDCN)
01
Z – approved
Package
7680687970013
No information made available
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
1 mg tagraxofuspum
trometamolum
natrii chloridum
50 mg sorbitolum
acidum hydrochloridum
natrii hydroxidum
aqua ad iniectabile
1.98 mg natrium
natrii chloridum
50 mg sorbitolum
acidum hydrochloridum
natrii hydroxidum
aqua ad iniectabile
1.98 mg natrium
Spezialitätenliste***
SL
-
-
16973.65
None
Yes
10%
No
Authorisation holder
7601001682429
Stemline Therapeutics Switzerland GmbH
Grafenaustrasse 3
6300 Zug (ZG)
Grafenaustrasse 3
6300 Zug (ZG)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.